Deactivating cancer cell gene boosts immunotherapy for head and neck cancers
UCLA discovery opens a pathway toward the discovery more effective treatments
Published 2021-03-23 · Original archive entry · Explore research explainers
By targeting an enzyme that plays a key role in head and neck cancer cells, researchers from the UCLA School of Dentistry were able to significantly slow the growth and spread of tumors in mice and enhance the effectiveness of an immunotherapy to which these types of cancers often become resistant.
Their findings, END
Their findings, END